CDH1 and cancer: Preclinical studies have shown that Astragalus injection can promote the expression of E-cadherin and reduce the expression of β-catenin in EC cells, thereby inhibiting the WNT signalling pathway to exert anti-cancer effects (Xiaoming et al., 2016).